Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. - Wikidata - wikimedia - TriplyDB

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.

http://www.wikidata.org/entity/Q36403391

about

Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 KIR/HLA pleiotropism: protection against both HIV and opportunistic infections Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).Complete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: novel insights into nonhuman primate KIR gene content and organization.Effects of MHC class I alleles on licensing of Ly49A+ NK cells.KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation.Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studies.KIR3DL01 recognition of Bw4 ligands in the rhesus macaque: maintenance of Bw4 specificity since the divergence of apes and Old World monkeys Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.KIR/HLA interactions and pathogen immunity Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease.Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex.CXCL12 rs266085 and TNF-α rs1799724 polymorphisms and susceptibility to cervical cancer in a Chinese population.Killer-cell immunoglobulin-like receptors and malaria caused by Plasmodium falciparum in The Gambia.Activating KIR/HLA complexes in classic Kaposi's Sarcoma Human papillomavirus immunization is associated with increased expression of different innate immune regulatory receptors Understanding how combinations of HLA and KIR genes influence disease Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.Relationship between hWAPL polymorphisms and cervical cancer susceptibility.Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.The Yin and Yang of HLA and KIR in human disease Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study HLA alleles determine differences in human natural killer cell responsiveness and potency.Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms.Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma.Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009.Licensing of natural killer cells by self-major histocompatibility complex class I.

P2860

Q27317377-A8C7C32D-EE49-473F-B371-067EF8C3BEA7 Q28277389-EAAD6E53-AC95-46F2-973C-A3941DC61DA9 Q28469038-C2009050-2178-479F-83EC-E55C863169B5 Q28730698-04356327-9FD7-4F48-8C2E-F32047244F3A Q30491962-27A58A64-3655-4492-8AED-41C42E648ACA Q31037177-42BCCD3D-3EB3-491B-80AE-1637BA7966CE Q33283515-E1789BB4-E3F0-41E9-B3B9-49BE6B02E6D6 Q33624846-35DC782E-530D-4C72-BF3D-AC8423BA92B4 Q33672480-479AB130-8F18-4F4D-8FCC-B770FD2FFFCB Q33704001-14B17B16-F7A4-4AC1-ACB1-1FB983FA5431 Q33822824-86352F21-63BC-4B3D-B146-4FBDE9FA3D59 Q33851496-1D0D4D61-217C-4B74-9994-E7470AC3D17B Q34017594-83146B22-11C3-40D2-AC7E-72C6CE38AE48 Q34056087-FC66503C-ED7F-44FD-A28A-EA08948EB47D Q34084137-8058014B-F50A-4347-BBE1-FA5E316CF832 Q34172209-5B32FB4C-E849-421F-8F28-E76BE2C20909 Q34192841-A0040685-B8B8-45F1-B28A-87C238ED1F99 Q34307792-90690BF0-09A4-4D00-BE0B-DA42EABEAAB0 Q34595508-3221FC90-616D-496A-B997-3F3FDF5AA487 Q34627802-F041A41D-EC54-45DB-B3A5-B773D2CDDFCB Q35001169-D8F3297B-77A7-47AF-A795-A75EB8A4BB04 Q35610533-D4818E19-FE72-43DF-B7F6-53DBAB18B033 Q35693475-1087887E-ACF1-464C-B764-7B6441704EE7 Q35797231-6455CD8C-546C-47BA-981D-287129E8BAA4 Q35854388-BE3CCC5E-C2E6-4591-99A9-2799FF8C6CAB Q35873703-09C5203F-E767-4153-81AE-7CD49227C2AF Q36048703-5032CA04-2AEA-44C1-8A2F-BD4E13033EEA Q36086249-2B2639B1-DCEA-4133-8BD2-FC3634E92FBE Q36088979-2572A078-385B-4D66-84DB-CD1E5C9C3F3A Q36228467-903D1E4A-AF87-461D-BF14-4E4BE679D11B Q36229197-BC634514-6FDE-4AC6-82DE-BF96B7F6859C Q36375660-5CD25C8E-2A69-4F4F-8338-4B98751DED90 Q36407362-0637541D-BB11-4488-8E19-B32EAE867764 Q36410540-621D7438-2169-4AAE-9BFE-BCE29A8949B9 Q36481429-51C93463-F7A1-4F59-A03D-BF059A45F502 Q36498481-47E94E68-3D86-4564-917E-E4380388C0F7 Q36569959-C7B2C27F-925C-4DF2-9047-FB8E54484CCE Q36610989-5F1CE8F4-54DF-4FF9-A05F-56BC19B338E4 Q36621051-FD49B7AC-B285-4B18-B030-114683D18949 Q36652187-55F720B2-225A-4338-8588-C740196813FE

P2860

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.

http://www.wikidata.org/entity/Q36403391

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Hierarchy of resistance to cer ...... human leukocyte antigen loci.

@ast

Hierarchy of resistance to cer ...... human leukocyte antigen loci.

@en

type

label

Hierarchy of resistance to cer ...... human leukocyte antigen loci.

@ast

Hierarchy of resistance to cer ...... human leukocyte antigen loci.

@en

prefLabel

Hierarchy of resistance to cer ...... human leukocyte antigen loci.

@ast

Hierarchy of resistance to cer ...... human leukocyte antigen loci.

@en

P1433

Q36403391-3C32B29F-A726-465E-B04D-8C06B46A36F4

P1476

Q36403391-48BC9F1A-2CAE-45D1-967E-B9206EE00EE8

P2093

Q36403391-09CFCC68-BEBE-4D4E-8354-6792032ABB5D

Q36403391-24BEA0F1-87E9-40E7-9914-5AF345277860

Q36403391-31475924-7E42-42FF-AC09-BB4F81CE3DE1

Q36403391-5F4D9A86-491C-4572-A328-7EACF0162CD1

Q36403391-6AE61EBA-B5EA-4D34-A58D-36A6974316F0

Q36403391-ABF00674-1664-4E82-AA66-D0FB3877A2D7

Q36403391-EC18C8AF-AB57-4E81-900F-3079648DC1B2

Q36403391-EDEC0609-99F3-419D-A74C-E87F0EE4C15D

Q36403391-F0C91005-1A70-4A3F-B417-1B21C4FFBF0C

P2860

Q36403391-0233306E-2415-4671-9E27-C1DC0354F987

Q36403391-0DF14A97-DA1F-4D03-AE2F-1711B51F3F16

Q36403391-2639AD9B-03B7-438A-B4BA-6E24E9009BE4

Q36403391-3FD02609-9398-493A-BE19-206A758B0A33

Q36403391-51A37D2D-FB2B-47F8-B3DA-95795E58F505

Q36403391-51CF0888-370D-4E69-9E1C-968602EEC564

Q36403391-52741FEE-A652-44D7-8A20-B4E291372208

Q36403391-581F4E3A-E152-4DC4-92AE-B1A7A1F4F478

Q36403391-607FFB73-168A-4595-A244-6496A3C9B1E5

Q36403391-7FE0D162-0C4C-4CA1-A928-24912E42E128

P304

Q36403391-5C962A2B-2D5A-49E9-A421-C037ADEEC9A3

P31

Q36403391-023B3215-D933-44A6-A450-21C47B2D315D

P356

Q36403391-0F35AFE5-DB42-43D3-9FF3-CA39DCF6E7C6

P407

Q36403391-1CE2CC1C-5355-4A46-8076-34A9E198B047

P433

Q36403391-79344FF3-7608-4A27-ABA5-8C49BD9ECCB3

P478

Q36403391-E6A6A177-061B-419F-A272-203B8652F29C

P50

Q36403391-0CC92358-CEDF-432C-9B4B-EB008AE0A9E0

Q36403391-40A35564-2E3A-4345-99BD-33DC2CA6D9A7

Q36403391-84BF11E6-F085-443B-907F-CAB645C01302

Q36403391-C7976797-1534-4A57-8FD6-31656FBC66A9

P577

Q36403391-571B5D9A-6BD2-4817-9351-B76CEFF100E3

P5875

Q36403391-DAC5FD14-401B-478E-80A4-2D05B07EDA53

P698

Q36403391-CFCBB94C-431F-4240-A0C4-BC0E1F6D5D6F

P932

Q36403391-900963E0-8787-4537-BB31-56297CEBD47C

P356

P1433

Journal of Experimental Medicine

P1476

Hierarchy of resistance to cer ...... human leukocyte antigen loci.

@en

P2093

Andrew Glass

http://www.w3.org/2001/XMLSchema#string

Jie Cheng

http://www.w3.org/2001/XMLSchema#string

Maureen P Martin

http://www.w3.org/2001/XMLSchema#string

Peter Schwartz

http://www.w3.org/2001/XMLSchema#string

Robert Kurman

http://www.w3.org/2001/XMLSchema#string

Rodrigue Mortel

http://www.w3.org/2001/XMLSchema#string

Rolando Herrero

http://www.w3.org/2001/XMLSchema#string

Sophia Wang

http://www.w3.org/2001/XMLSchema#string

Xiaojiang Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

HLA class I recognition by killer cell Ig-like receptors.

On measures of gametic disequilibrium

Interaction between the human NK receptors and their ligands.

Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica.

NK cells and NKT cells in innate defense against viral infections.

The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.

Viral modulation of NK cell immunity.

P304

1069-1075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20042158

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

201

http://www.w3.org/2001/XMLSchema#string

P50

Mary Carrington

Allan Hildesheim

Ana Cecilia Rodríguez

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7927632

http://www.w3.org/2001/XMLSchema#string

P698

15809352

http://www.w3.org/2001/XMLSchema#string

P932

2213116

http://www.w3.org/2001/XMLSchema#string